Although a fraction of AKIs have been produced, cell toxicity and other challenges should be taken into account because, sadly, no AKI has yet been demonstrated to be safe for use on patients in a clinical setting. To lessen toxicity, AKIs that effectively and specifically target cancer cells but sp...
26.12.22 12:44 PM - Comment(s)